Dna X (SONM) Invested Capital (2018 - 2026)

Dna X has reported Invested Capital for 9 years, with the latest figure at -$585000.0 in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 45.78% year-over-year to -$585000.0; the trailing twelve-month figure through Mar 2026 stood at -$585000.0 (up 45.78% YoY), and the FY2025 full-year result was -$7.8 million, down 36.56% from the prior year.
• Invested Capital for Q1 2026 stood at -$585000.0, up from -$7.8 million in the prior quarter.
• The five-year high for Invested Capital was $23.1 million in Q3 2023, with the low at -$7.8 million in Q4 2025.
• Historically, Invested Capital has averaged $10.8 million across 5 years, with a median of $15.3 million in 2024.
• Annual changes were most pronounced in 2023 — Invested Capital surged 203.69% — and 2024, when it sank 125.48%.
• Dna X's Invested Capital stood at $20.2 million in 2022, then climbed by 10.78% to $22.4 million in 2023, then sank by 125.48% to -$5.7 million in 2024, then slumped by 36.56% to -$7.8 million in 2025, then jumped by 92.48% to -$585000.0 in 2026.
• The last three Invested Capital figures came in at -$585000.0 (Q1 2026), -$7.8 million (Q4 2025), and -$701000.0 (Q3 2025), per Business Quant data.